Skip to Content

Andrew Srisuwananukorn

Andrew Srisuwananukorn, MD, is a hematologist and an Assistant Professor at the Ohio State University in the USA. Dr. Srisuwananukorn’s research entails integrating the use of novel computational tools to derive digital biomarkers that improve the care of myeloproliferative neoplasm (MPN) and acute myeloid leukemia (AML) patients. Currently, Dr. Srisuwananukorn is leading two multi-institutional investigations of contemporary image-based machine learning methods for disease classification using diagnostic bone marrow biopsy images of MPN and AML patients. For these investigations, Dr. Srisuwananukorn has been awarded the 2022-2023 Paul Carbone, MD Fellowship Award, from the ECOG-ACRIN cancer research group and the 2023-2024 Young Investigator Award from Conquer Cancer, the American Society of Clinical Oncology Foundation.

 

Back to top